FDA's Schwetz Is Acting Commissioner: RU-486 Appears To Be Touchstone
FDA Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of Commissioner Jane Henney, MD.
FDA Acting Deputy Commissioner Bernard Schwetz, PhD, will oversee the agency following the resignation of Commissioner Jane Henney, MD.